Liabilities Financial Impact Litigation Costs Penalties Damages Financial Penalties Financial Reporting Payments Risk Management Consumer Refunds Payouts Fines and Penalties Cost Analysis Arbitration Awards Lawsuit Costs Bayer Financials Roundup Lawsuit Settlements Shareholder Actions Investor Relations Shareholder Payments Environmental Compliance Costs Financial Reserves Government Settlements Bankruptcy Financing Patent Infringement Settlements JPMorgan Chase Moderna's Financial Obligations Compensation Payments Attorney Fees Compensation Claims Impact on Business Monetary Transactions Indemnification Amounts Interest Payments Government Regulations Provisions Shareholder Rights Expropriation Refunds Monsanto Impact on Financial Statements Market Penalties Patent Infringement Costs Class Action Lawsuits Bribery Settlements Damage Awards Damages Awards Market Impact Investor Rights Insurance Hush Money Payments Plea Agreements Severance Payments Impact on Companies Pharmaceutical Companies Put Options Reparations Abatement Funds Banking Cost Management Consumer Compensation Fines and Compensation Johnson & Johnson Reparatory Agreements Insurance Claims Indemnities Class Action Settlements Shareholder Lawsuits Regulatory Compliance
Want to see what podcasts are saying about this topic? Search across 130K+ podcasts. Explore Radar
The deal would resolve most state and reseller claims while leaving some opt-out suits and a 2027 trial as outstanding legal risks.
